These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10403917)
1. Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Nilsson N; Bremell T; Tarkowski A; Carlsten H Clin Exp Immunol; 1999 Jul; 117(1):63-9. PubMed ID: 10403917 [TBL] [Abstract][Full Text] [Related]
2. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Abdelnour A; Bremell T; Holmdahl R; Tarkowski A Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526 [TBL] [Abstract][Full Text] [Related]
3. TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. Hultgren O; Eugster HP; Sedgwick JD; Körner H; Tarkowski A J Immunol; 1998 Dec; 161(11):5937-42. PubMed ID: 9834074 [TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. Hultgren O; Kopf M; Tarkowski A J Immunol; 1998 May; 160(10):5082-7. PubMed ID: 9590259 [TBL] [Abstract][Full Text] [Related]
5. Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. Abdelnour A; Bremell T; Tarkowski A J Infect Dis; 1994 Jul; 170(1):94-9. PubMed ID: 8014527 [TBL] [Abstract][Full Text] [Related]
6. The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis. Verdrengh M; Kum W; Chow A; Tarkowski A Clin Exp Immunol; 1999 Nov; 118(2):268-70. PubMed ID: 10540189 [TBL] [Abstract][Full Text] [Related]
7. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651 [TBL] [Abstract][Full Text] [Related]
8. Interaction with complement receptor 1 (CD35) leads to amelioration of sepsis-triggered mortality but aggravation of arthritis during Staphylococcus aureus infection. Sakiniene E; Heyman B; Tarkowski A Scand J Immunol; 1999 Sep; 50(3):250-5. PubMed ID: 10447933 [TBL] [Abstract][Full Text] [Related]
9. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. Zhao YX; Tarkowski A J Immunol; 1995 Dec; 155(12):5736-42. PubMed ID: 7499861 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activation primes macrophages to clear bacterial infection. Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG Am Surg; 2003 Aug; 69(8):679-86; discussion 686-7. PubMed ID: 12953826 [TBL] [Abstract][Full Text] [Related]
13. Are B lymphocytes of importance in severe Staphylococcus aureus infections? Gjertsson I; Hultgren OH; Stenson M; Holmdahl R; Tarkowski A Infect Immun; 2000 May; 68(5):2431-4. PubMed ID: 10768927 [TBL] [Abstract][Full Text] [Related]
14. Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Majumdar S; Dutta K; Manna SK; Basu A; Bishayi B Inflammation; 2011 Aug; 34(4):269-82. PubMed ID: 20658182 [TBL] [Abstract][Full Text] [Related]
15. The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis. Verdrengh M; Tarkowski A Scand J Immunol; 2008 Mar; 67(3):253-9. PubMed ID: 18226012 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection. Narita K; Hu DL; Asano K; Nakane A Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736 [TBL] [Abstract][Full Text] [Related]